Aehr Test Systems Dossier - Source-backed chat

Aehr Test Systems

AEHRNASDAQ

SectorInformation Technology

IndustrySemiconductor Equipment & Materials

Beta (adjusted)2.38

Intrinsic Value $21.45median of 2 methodsbased on filings through 29 May 2026

Market Price $99.62Price as of 30 Sep 2026

Significantly overvaluedIntrinsic value is 78% below the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

marker beyond scale (-78%)

Data confidence Sign in to view data confidence

Market Cap $3.3B

Enterprise Value $3.1B

Shares Outstanding 30.7M diluted

Next Earnings Date2 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Aehr Test Systems (AEHR) has established a strong technological position and a robust order book, emerging as a critical player in wafer-level and package-level burn-in testing for AI chips, silicon photonics, and automotive semiconductors. The company has successfully diversified its growth engines, securing a record $41 million production order from its lead hyperscale AI customer and expanding its footprint in the high-power optical interconnect market. However, the stock is currently priced to perfection, trading at an extremely elevated multiple of approximately 35x FY2027 revenue estimates following a massive 858% run-up over the past year. This valuation leaves no margin of safety for new investors, especially given that the company has experienced two consecutive years of revenue declines and significant gross margin compression to the mid-30s. While the long-term structural setup remains highly attractive, near-term execution risks and valuation stretch justify a Hold rating, with a more favorable entry point on a pullback to the mid-$60s.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets4 analysts · as of 18 Aug 2026

Low · most bearish analyst$110.00

Mean target$130.00

High · most bullish analyst$175.00

Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

The bear case reflects potential delays in customer rollouts, order pushouts, or increased competition in the wafer-level burn-in space. Customer concentration remains high, and a slowdown in hyperscaler capital expenditures directly impacts Aehr's order book. Gross margins remain compressed in the mid-30s due to pricing pressure and underutilized manufacturing capacity, leading to continued net losses and a sharp contraction in the stock's multiple.

Base CaseCentral scenario

The base case assumes Aehr successfully executes on its record $41 million production order and continues to scale its Sonoma and FOX-XP platforms. Revenue is expected to recover strongly in FY2027, driven by the AI infrastructure build-out and silicon photonics adoption. Gross margins gradually recover toward the low-to-mid 40s as the product mix shifts back to higher-margin proprietary consumables (WaferPaks and DiePaks). Valuation multiples compress to more reasonable historical ranges as earnings materialize.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Leading technology position in wafer-level and package-level burn-in testing, which is increasingly critical as semiconductor complexity and failure costs rise.
Strong order momentum with a record $41 million production order from a lead hyperscale AI customer and over $92 million in second-half bookings.
Successful diversification into silicon photonics and custom AI ASICs, reducing historical reliance on the electric vehicle (SiC) market.
High-margin 'razor-and-blade' business model, where initial system sales drive recurring, high-margin sales of proprietary WaferPak and DiePak consumables.

Key Investment Risks

Extremely stretched valuation trading at ~35x FY2027 revenue estimates, leaving no margin of safety for execution hiccups.
High customer concentration, making the revenue trajectory highly sensitive to the capital expenditure plans of a few key customers.
Recent financial weakness, including two consecutive years of revenue declines and gross margin compression to the mid-30s.
High stock price volatility (Beta of ~3.18) and elevated short interest, exposing investors to sharp macro-driven or technical swings.

Thesis Invalidation Triggers

Cancellation or significant delay of the record $41 million production order scheduled for FY2027.
Failure to return to non-GAAP profitability in Q4 Fiscal 2026.
A broader slowdown in hyperscale AI infrastructure capital expenditures.
Loss of market share to emerging competitors in the high-power wafer-level burn-in segment.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.